Rapamycin, also known as sirolimus, shows its unique inhibitory effects by binding to MTOR and has been used extensively in transplantation to prevent organ rejection [14,15], and recently, its application has expanded to cancer therapy [16]. The gene discussed is MTOR; the disease is cancer.